Morphic Holding Inc Stock, NASDAQ:MORF
35 Gatehouse Drive A2, Waltham, Massachusetts 02451
United States of America
Number of Employees: 89
Morphic Holding, Inc. operates as a biopharmaceutical company, which engages in the research and development of oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas. The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA.